Transcranial Doppler Ultrasound: Sickle Cell Stroke Risk

Transcranial Doppler (TCD) ultrasound non-invasively measures cerebral arterial blood-flow velocity and is the validated tool for primary stroke prevention in children with sickle cell anaemia. Elevated velocities in the distal internal carotid and middle cerebral arteries identify children at high risk of overt stroke who benefit from chronic transfusion, as established by the STOP trial. Annual screening from age 2 to 16 years is a cornerstone of paediatric sickle cell care and is especially important in high-burden African populations.

Indications

Annual stroke-risk screening in children with HbSS or HbS-beta-zero thalassaemia aged 2-16 years
Confirmation and follow-up of previously conditional or abnormal velocities
Monitoring response to chronic transfusion or hydroxyurea therapy
Risk stratification before decisions about transfusion or transcranial-Doppler-guided management
Baseline assessment in a newly diagnosed child entering a stroke-prevention programme
Re-evaluation after clinical events or change in therapy

Contraindications & Cautions

No contraindications; TCD is non-invasive, non-ionising and repeatable
Inadequate temporal acoustic window (more common with age) may prevent interpretable insonation
Acute illness, fever, pain crisis, recent transfusion or sedation can transiently alter velocities - defer routine screening until the child is at steady state
Operator training and standardised technique are essential for validity

Patient Preparation

Screen at steady state, not during acute crisis, infection or shortly after transfusion
No fasting or sedation required; a calm, cooperative, resting child gives the best study
Explain the painless procedure to child and caregiver and obtain consent/assent
Record recent transfusion history, haemoglobin and current therapy
Position the child comfortably, seated or supine, with access to both temporal windows

Technique & Parameters

Use non-imaging (STOP-protocol) or imaging TCD; the STOP trial thresholds are based on the non-imaging technique
Insonate through the transtemporal window with a 2 MHz pulsed-wave probe
Measure time-averaged mean of the maximum velocity (TAMMV) in the distal ICA and proximal/middle MCA bilaterally
Interrogate anterior and posterior cerebral arteries and basilar/terminal ICA as feasible
Record depth, angle and window for reproducibility; use the highest reliable TAMMV to classify
Note that imaging (TCDI) values run approximately 10-15% lower than STOP non-imaging thresholds - apply the correct reference set

Systematic Review

Confirm adequate temporal windows bilaterally before interpreting
Measure TAMMV in both MCAs and distal ICAs
Document ACA, PCA and basilar velocities where obtainable
Compare left versus right for significant asymmetry
Assess waveform shape for turbulence or low-velocity signals suggesting stenosis or occlusion
Check for absent or very low velocity (possible high-grade stenosis/occlusion) which is also high risk
Cross-check values against steady-state status and recent transfusion

Key Findings & Significance

Abnormal (high risk): TAMMV >=200 cm/s in the ICA or MCA - indication for chronic transfusion
Conditional: TAMMV 170-199 cm/s - repeat within a shorter interval
Normal: TAMMV <170 cm/s - continue annual screening
Very low velocity (<70 cm/s) in a major vessel may indicate severe stenosis/occlusion and warrants MRA
Marked interhemispheric asymmetry raising concern for focal vasculopathy
STOP trial showed transfusion reduces first stroke risk by roughly 90% in the abnormal group

Differential Considerations

Elevated velocity: sickle vasculopathy/stenosis, anaemia-driven hyperdynamic flow, fever/crisis, technical angle error
Low velocity in a major artery: high-grade stenosis, occlusion, or poor insonation angle
Asymmetric velocities: focal stenosis, moyamoya collateralisation, congenital variant
Transiently high values post-anaemia correction: recent transfusion effect
Normal TCD with symptoms: silent infarction or small-vessel disease not detected by TCD - proceed to MRI
Absent signal: inadequate window versus true occlusion

Pearls & Pitfalls

Use the correct reference thresholds for the technique (non-imaging STOP versus imaging TCDI)
Screen only at steady state - acute anaemia and fever falsely elevate velocities
A recent transfusion lowers velocities and can mask true risk
Both abnormally high and abnormally low velocities carry stroke risk
TCD assesses stroke risk, not established infarcts - normal TCD does not exclude silent infarction
Confirm abnormal results before committing to lifelong transfusion; ensure consistent operator technique

Structured Report

State technique (imaging versus non-imaging) and adequacy of temporal windows
Report TAMMV for both MCAs and distal ICAs with the highest value driving classification
Categorise as normal, conditional or abnormal per STOP thresholds
Note asymmetry, low-velocity vessels or turbulent waveforms
Record steady-state status and recent transfusion history
Impression: give risk category, recommended re-screen interval or referral for transfusion, and MRI/MRA if vasculopathy suspected

References

Adams RJ et al., STOP Trial: Prevention of a First Stroke by Transfusions in Children with Sickle Cell Anemia and Abnormal TCD (NEJM 1998)
American Society of Hematology Guidelines: Cerebrovascular Disease in Sickle Cell Disease
NHLBI Evidence-Based Management of Sickle Cell Disease
STOP protocol TCD examination standards

Educational clinical decision support only. Protocols vary by institution and equipment; always confirm with a qualified radiologist and local guidelines before clinical use.

Transcranial Doppler Ultrasound: Sickle Cell Stroke Risk

📋 Indications

⛔ Contraindications & Cautions

🧑‍⚕️ Patient Preparation

⚙️ Technique & Parameters

🔎 Systematic Review

🩻 Key Findings & Significance

🧠 Differential Considerations

💡 Pearls & Pitfalls

📝 Structured Report

📚 References